Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.46 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.46 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.46 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.46 |
| ▸ | MMP9 | P14780 | 6/20 | 0.45 |
| ▸ | MMP2 | P08253 | 4/20 | 0.41 |
| ▸ | MMP8 | P22894 | 4/20 | 0.41 |
| ▸ | MMP13 | P45452 | 4/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Amobarbital SCHEMBL1818832 | 0.98 | LMNA (0.61) | LMNAALDH1A1KDM4ECYP3A4GABRB3 | |
| Amobarbital SCHEMBL43780 | 0.98 | LMNA (0.61) | LMNAALDH1A1KDM4ECYP3A4GABRB3 | |
| Amobarbital SCHEMBL15419613 | 0.96 | LMNA (0.59) | LMNAALDH1A1KDM4ECYP3A4GABRB3 | |
| Amobarbital SCHEMBL9869615 | 0.96 | LMNA (0.59) | LMNAALDH1A1KDM4ECYP3A4GABRB3 | |
| Amobarbital SCHEMBL10911494 | 0.96 | LMNA (0.59) | LMNAALDH1A1KDM4ECYP3A4GABRB3 | |
| Amobarbital SCHEMBL30207759 | 0.96 | LMNA (0.59) | LMNAALDH1A1KDM4ECYP3A4GABRB3 | |
| Amobarbital SCHEMBL28207058 | 0.94 | LMNA (0.57) | LMNAALDH1A1KDM4ECYP3A4GABRB3 | |
| Amobarbital SCHEMBL28062223 | 0.94 | LMNA (0.57) | LMNAALDH1A1KDM4ECYP3A4GABRB3 | |
| Amobarbital SCHEMBL13723415 | 0.90 | LMNA (0.52) | LMNAALDH1A1KDM4ECYP3A4GABRB3 | |
| SCHEMBL5438948 | 0.88 | LMNA (0.57) | LMNAALDH1A1KDM4ECYP3A4GABRB3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2369 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260076872-A1 | POLYMER VIALS WITH SUBSTANTIALLY FLAT BOTTOMS AND INJECTION STRETCH BLOW MOLDING METHODS FOR MAKING THE SAME | SIO2 MEDICAL PRODUCTS LLC (US) | 2026-03-19 | — | — | US | claimed |
| US-20250242092-A1 | SiOx BARRIER FOR PHARMACEUTICAL PACKAGE AND COATING PROCESS | SIO2 MEDICAL PRODUCTS INC (US) | 2025-07-31 | — | — | US | claimed |
| US-12257371-B2 | SiOx barrier for pharmaceutical package and coating process | SIO2 MEDICAL PRODUCTS, LLC (US) | 2025-03-25 | — | — | US | claimed |
| US-20240074944-A1 | PECVD COATED PHARMACEUTICAL PACKAGING | OAKTREE FUND ADMINISTRATION, LLC | 2024-03-07 | — | — | US | claimed |
| CN-117241773-A | Polymer medicine bottle with standard external dimensions and reduced internal volume | SIO2医疗产品有限公司 | 2023-12-15 | — | — | CN | claimed |
| US-20230381195-A1 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF TRAUMATIC BRAIN INJURY (TBI) AND RELATED DISORDERS | MEHRA AKHIL (US) | 2023-11-30 | — | — | US | claimed |
| US-20230303305-A1 | METHOD AND PACKAGE FOR REDUCING THE DEGRADATION OF A DRUG AND/OR EXCIPIENT, E.G. POLYSORBATE STABILIZER, IN A PHARMACEUTICAL PRODUCT | OAKTREE FUND ADMINISTRATION, LLC | 2023-09-28 | — | — | US | claimed |
| EP-4247316-A1 | POLYMER VIALS HAVING STANDARD EXTERNAL DIMENSIONS AND REDUCED INTERNAL VOLUME | SiO2 Medical Products, Inc. (US) | 2023-09-27 | — | — | EP | claimed |
| US-20230277415-A1 | POLYMER VIALS HAVING STANDARD EXTERNAL DIMENSIONS AND REDUCED INTERNAL VOLUME | SIO2 MEDICAL PRODUCTS, INC. | 2023-09-07 | — | — | US | claimed |
| US-20230263957-A1 | ATOMIC LAYER DEPOSITION COATED PHARMACEUTICAL PACKAGING AND IMPROVED SYRINGES AND VIALS, E.G. FOR LYOPHILIZED/COLD-CHAIN DRUGS/VACCINES | OAKTREE FUND ADMINISTRATION, LLC | 2023-08-24 | — | — | US | claimed |
| EP-1095136-A1 | CELLS AND ANIMALS DEFICIENT IN PROTEIN KINASE C EPSILON | Messing, Robert O. (US) | 2001-05-02 | — | — | EP | claimed |
| EP-0983060-A1 | SOLID POROUS MATRICES AND METHODS OF MAKING AND USING THE SAME | IMARX PHARMACEUTICAL CORP. (US) | 2000-03-08 | — | — | EP | claimed |
| WO-2000001805-A1 | CELLS AND ANIMALS DEFICIENT IN PROTEIN KINASE C EPSILON | MESSING ROBERT O (US) | 2000-01-13 | — | — | WO | claimed |
| CN-2329059-Y | Quick look-up instrument for incompatibility of drugs in a prescription of 159 kind of injections | GU CHUNWEI (CN) | 1999-07-14 | — | — | CN | claimed |
| WO-1998051282-A1 | SOLID POROUS MATRICES AND METHODS OF MAKING AND USING THE SAME | IMARX PHARMACEUTICAL CORP. (US) | 1998-11-19 | — | — | WO | claimed |
| US-5770222-A | Therapeutic drug delivery systems | IMARX PHARMACEUTICAL CORP. (US) | 1998-06-23 | — | — | US | claimed |
| EP-0303853-A2 | Polymer blends having reverse phase morphology for controlled delivery of bioactive agents | EASTMAN CHEMICAL COMPANY (US) | 1989-02-22 | — | — | EP | claimed |
| US-4795641-A | CELLULOSE ACETATES | EASTMAN KODAK COMPANY (US) | 1989-01-03 | — | — | US | claimed |
| EP-0079329-A1 | MEDICINAL COMPOSITION | JENKINSON, Alfred (GB) | 1983-05-25 | — | — | EP | claimed |
| WO-1982003986-A1 | MEDICINAL COMPOSITION | JENKINSON ALFRED | 1982-11-25 | — | — | WO | claimed |